Additionally, monocytes/macrophages expressed APRIL and MIF may also contribute immunosuppression of BM microenvironment and then promotes the relapse of R/R-MM after BCMA CAR-T treatment. The gene discussed is MIF; the disease is Miyoshi myopathy.